PARMAX

Parmax Pharma Share PriceParmax Pharma

₹29.00
-1.51 (-4.95%)
As on 28 March, 2023 | 08:45 BSE: 540359 NSE: PARMAX

Parmax Pharma Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Parmax Pharma

Start SIP

Parmax Pharma Share Price

  • Over 1 Month -9.8%
  • Over 3 Month -35.34%
  • Over 6 Month -12.12%
  • Over 1 Year -33.64%

Parmax Pharma Key Statistics

Parmax Pharma Investment Rating

  • Master Rating:
  • Parmax Pharma has an operating revenue of Rs. 16.13 Cr. on a trailing 12-month basis. An annual revenue de-growth of -30% needs improvement, Pre-tax margin of 2% needs improvement, ROE of 2% is fair but needs improvement. The company has a debt to equity of 76%, which is bit higher. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 18 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 94 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength

N/A

Price Strength

Buyer Demand

Group Rank

Parmax Pharma Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 5227
Operating Expenses Qtr Cr 3226
Operating Profit Qtr Cr 20-11
Depreciation Qtr Cr 0000
Interest Qtr Cr 0000
Tax Qtr Cr 0000
Net Profit Qtr Cr 2-1-10

Parmax Pharma Technicals

EMA & SMA

Current Price
₹29.
-1.51 (-4.95%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 32.2
  • 50 Day
  • 33.82
  • 100 Day
  • 34.88
  • 200 Day
  • 36.23
  • 20 Day
  • 32.25
  • 50 Day
  • 34.16
  • 100 Day
  • 35.81
  • 200 Day
  • 34.65

Parmax Pharma Resistance and Support

PIVOT
₹30.53
Resistance
First Resistance 30.54
Second Resistance 30.57
Third Resistance 30.58
RSI 37.18
MFI 8.97
MACD Single Line -0.9
MACD -1.06
Support
First Resistance 30.5
Second Resistance 30.49
Third Resistance 30.46

Parmax Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 805 80,500 100
Week 396 37,149 93.93
1 Month 661 50,432 76.26
6 Month 2,511 196,140 78.12

Parmax Pharma Result Highlights

Parmax Pharma Synopsis

BSE-Medical-Diversified

Parmax Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 18.25 Cr. and Equity Capital is Rs. 4.45 Cr. for the Year ended 31/03/2022. Parmax Pharma Ltd. is a Public Limited Listed company incorporated on 02/11/1994 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24231GJ1994PLC023504 and registration number is 023504.
Market Cap 11
Sales 16
Shares in Float 0.26
No of funds
Yield
Book Value 2.17
U/D Vol ratio 0.7
LTDebt / Equity 76
Alpha -0.04
Beta 0.14

Parmax Pharma

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 30.8%30.8%30.8%
Individual Investors 65.36%65.37%68%
Others 3.84%3.83%1.2%

Parmax Pharma Management

Name Designation
Mr. Umang Alkesh Gosalia Managing Director
Mr. Pramay A Chhatra Independent Director
Ms. Ami R Shah Independent Director

Parmax Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Parmax Pharma FAQs

What is Share Price of Parmax Pharma ?

Parmax Pharma share price is ₹29 As on 28 March, 2023 | 08:31

What is the Market Cap of Parmax Pharma ?

The Market Cap of Parmax Pharma is ₹10.8 Cr As on 28 March, 2023 | 08:31

What is the P/E ratio of Parmax Pharma ?

The P/E ratio of Parmax Pharma is -33.6 As on 28 March, 2023 | 08:31

What is the PB ratio of Parmax Pharma ?

The PB ratio of Parmax Pharma is 1.6 As on 28 March, 2023 | 08:31

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number